Catalyst Wire Dossier Catalyst Wire Dossier

Octreotide Subcutaneous Depot

octreotide · Camurus AB
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Octreotide Subcutaneous Depot, covering 2024-04-25 to 2026-08-20. Get the full timeline:

Most recent: Clinical Trial Results: A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly [Phase 3]

See pricing